Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto C Boerman

Showing results (311-320 of 319) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 319 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2019
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using <sup>68</sup>Ga-RGD PET/CTDaphne Lobeek, Frédérique C M Bouwman, Erik H J G Aarntzen, et al.
Nature Biotechnology|November 1, 2005
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapyI Jolanda M de Vries, W Joost Lesterhuis, Jelle O Barentsz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imagingErik H J G Aarntzen, Mangala Srinivas, Johannes H W De Wilt, et al.
Cancer Research|March 26, 2009
In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patientsDanita H Schuurhuis, Pauline Verdijk, Gerty Schreibelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patientsPauline Verdijk, Erik H J G Aarntzen, W Joost Lesterhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patientsW Joost Lesterhuis, I Jolanda M de Vries, Gerty Schreibelt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2019
Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinomaSarah R Verhoeff, Suzanne C van Es, Eline Boon, et al.
Mabs|May 11, 2021
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapyInja Waldhauer, Valeria Gonzalez-Nicolini, Anne Freimoser-Grundschober, et al.
Cancer Immunology, Immunotherapy : CII|February 11, 2016
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicityKalijn F Bol, Erik H J G Aarntzen, Jeanette M Pots, et al.
Pageof 32

Showing results (311-320 of 319) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2019
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using <sup>68</sup>Ga-RGD PET/CTDaphne Lobeek, Frédérique C M Bouwman, Erik H J G Aarntzen, et al.
Nature Biotechnology|November 1, 2005
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapyI Jolanda M de Vries, W Joost Lesterhuis, Jelle O Barentsz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imagingErik H J G Aarntzen, Mangala Srinivas, Johannes H W De Wilt, et al.
Cancer Research|March 26, 2009
In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patientsDanita H Schuurhuis, Pauline Verdijk, Gerty Schreibelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patientsPauline Verdijk, Erik H J G Aarntzen, W Joost Lesterhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patientsW Joost Lesterhuis, I Jolanda M de Vries, Gerty Schreibelt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2019
Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinomaSarah R Verhoeff, Suzanne C van Es, Eline Boon, et al.
Mabs|May 11, 2021
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapyInja Waldhauer, Valeria Gonzalez-Nicolini, Anne Freimoser-Grundschober, et al.
Cancer Immunology, Immunotherapy : CII|February 11, 2016
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicityKalijn F Bol, Erik H J G Aarntzen, Jeanette M Pots, et al.
Pageof 32